These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 11173728

  • 1. [Prevalence and prognostic value of serum anti-p53 antibodies in hepatocellular carcinoma. A study of 159 patients].
    Sitruk V, Vaysse J, Chevret S, Ganne-Carrie N, Christidis C, Trinchet J, Beaugrand M.
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1159-63. PubMed ID: 11173728
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.
    Saffroy R, Lelong JC, Azoulay D, Salvucci M, Reynes M, Bismuth H, Debuire B, Lemoine A.
    Br J Cancer; 1999 Feb; 79(3-4):604-10. PubMed ID: 10027337
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
    Parasole R, Izzo F, Perrone F, Pignata S, Galati MG, Leonardi E, Castiglione F, Orlando R, Castello G, Esposito G, Gallo C, Daniele B.
    Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the pattern and prognostic implications of anti-p53 in hepatocellular carcinoma.
    Akere A, Otegbayo JA.
    Singapore Med J; 2007 Jan; 48(1):41-4. PubMed ID: 17245515
    [Abstract] [Full Text] [Related]

  • 8. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Clin Gastroenterol; 2009 Jan; 43(5):482-8. PubMed ID: 19197197
    [Abstract] [Full Text] [Related]

  • 9. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
    Huo TI, Huang YH, Lui WY, Wu JC, Lee PC, Chang FY, Lee SD.
    Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.
    Xu HX, Lu MD, Xie XY, Yin XY, Kuang M, Chen JW, Xu ZF, Liu GJ.
    Clin Radiol; 2005 Sep; 60(9):1018-25. PubMed ID: 16124984
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T, Sakaguchi S, Miyajima Y, Hatono N, Tohara K, Nakabayashi S, Yao T, Kokawa H, Hirano M, Okumura M.
    Cancer; 2002 Aug 01; 95(3):596-604. PubMed ID: 12209753
    [Abstract] [Full Text] [Related]

  • 12. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
    Lin CY, Kuo CS, Lu CL, Wu MY, Huang RF.
    Nutr Cancer; 2010 Aug 01; 62(2):190-7. PubMed ID: 20099193
    [Abstract] [Full Text] [Related]

  • 13. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.
    Dig Liver Dis; 2008 Nov 01; 40(11):882-9. PubMed ID: 18339595
    [Abstract] [Full Text] [Related]

  • 14. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
    Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga H, Imaizumi T, Kojiro M, Sata M.
    Liver Int; 2007 Oct 01; 27(8):1091-7. PubMed ID: 17845537
    [Abstract] [Full Text] [Related]

  • 15. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    Liver Int; 2007 Aug 01; 27(6):772-81. PubMed ID: 17617120
    [Abstract] [Full Text] [Related]

  • 16. Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma.
    Maehara Y, Kakeji Y, Watanabe A, Baba H, Kusumoto H, Kohnoe S, Sugimachi K.
    Cancer; 1999 Jan 15; 85(2):302-8. PubMed ID: 10023696
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K, Shigematsu H, Irie K, Ishibashi H.
    Hepatogastroenterology; 2003 Jan 15; 50(54):2022-7. PubMed ID: 14696457
    [Abstract] [Full Text] [Related]

  • 18. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
    Ikoma J, Kaito M, Ishihara T, Nakagawa N, Kamei A, Fujita N, Iwasa M, Tamaki S, Watanabe S, Adachi Y.
    Hepatogastroenterology; 2002 Jan 15; 49(43):235-8. PubMed ID: 11941963
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
    Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Bernardi M, Trevisani F.
    Am J Gastroenterol; 2006 Mar 15; 101(3):524-32. PubMed ID: 16542289
    [Abstract] [Full Text] [Related]

  • 20. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM, Shiha GE, Ismail H, Mansy SE, El-Sherbiny R, El-Dosoky I.
    Clin Biochem; 2009 Apr 15; 42(6):455-61. PubMed ID: 19063876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.